This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vista Partners Publishes February 2012 Newsletter

 

SAN FRANCISCO, Feb. 2, 2012 /PRNewswire/ -- Vista Partners ("Vista") announced today that it published its FREE monthly newsletter for the month of February. Each monthly newsletter from Vista contains macroeconomic thoughts from its Principal Analyst, Ross Silver, and monthly highlights of each covered company.   

In the February Newsletter, Ross Silver, Principal Analyst at Vista Partners states the following regarding ADVENTRX Pharmaceutical, Inc. (NYSE Amex: ANX), "ADVENTRX seems to be bouncing back from year-end tax loss selling and it seems investors are focused on the initiation of two Phase 3 trials scheduled to begin this year. ANX currently trades at a negative enterprise value which means its market cap is less than it cash position. It seems that little to no value is being given to the Company's two late stage clinical candidates. This would seem to make absolutely no sense and we doubt the opportunity to purchase shares of ADVENTRX for less than the company's cash value per share will last for much longer especially considering both Phase 3 trials are fully funded to completion."



To download the FREE February Newsletter, please visit http://www.vistapglobal.com and click the "download newsletter" icon to gain access. 

About Vista Partners:Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of profitable investment ideas.

Please remember to follow us on Twitter @VistaPResearch & Facebook at Vista-Partners to receive updates, thoughts and ideas about and our coverage universe of companies and more ...

Disclaimer & Disclosure:We encourage readers to view a complete list of disclaimers and disclosures on our website www.vistapglobal.com.

Contact:877.215.4813 or info@vistapglobal.com

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs